Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Value Market Research | PRODUCT CODE: 1521384

Cover Image

PUBLISHER: Value Market Research | PRODUCT CODE: 1521384

Global Congestive Heart Failure Treatment Device Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

PUBLISHED:
PAGES: 130 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 3920
PDF (10-user License)
USD 4730
PDF (Corporate User License)
USD 7430

Add to Cart

The global demand for Congestive Heart Failure Treatment Device Market is presumed to reach the market size of nearly USD 52.14 Billion by 2032 from USD 28.22 Billion in 2023 with a CAGR of 7.06% under the study period 2024-2032.

Congestive Heart Failure (CHF) treatment devices encompass a diverse range of medical devices specifically designed to manage and improve the symptoms of heart failure. These devices play a crucial role in providing therapeutic support to patients with CHF, a chronic condition in which the heart struggles to efficiently pump blood, leading to fluid accumulation in the lungs other areas of the body. The primary goal of congestive heart failure treatment devices is to enhance cardiac function, alleviate symptoms, and enhance patients' overall quality of life.

MARKET DYNAMICS

The CHF treatment device market is witnessing significant growth driven by the increasing prevalence of heart failure globally, particularly among elderly populations. As life expectancy rises and lifestyles evolve, the incidence of heart failure continues to escalate, necessitating advanced treatment options, including implantable devices such as pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. Technological advancements in cardiac care are also pivotal drivers of market growth. Innovations such as miniaturization of devices, wireless connectivity for remote monitoring, and improved battery life are enhancing the efficacy and usability of congestive heart failure treatment devices. These advancements improve patient outcomes by providing real-time data to healthcare providers and contribute to better management of chronic conditions through personalized and timely interventions.

Moreover, favorable reimbursement policies and increasing healthcare expenditure are bolstering market expansion. Governments and healthcare organizations increasingly recognize the cost-effectiveness of preventive measures and advanced treatment options for managing chronic diseases like heart failure, thereby supporting the adoption of congestive heart failure treatment devices. However, the high initial costs associated with device implantation and maintenance and stringent regulatory requirements for device approval and patient safety pose barriers to market entry for smaller congestive heart failure treatment device manufacturers.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Congestive Heart Failure Treatment Device. The growth and trends of Congestive Heart Failure Treatment Device industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Congestive Heart Failure Treatment Device market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

  • Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD))
  • External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator)
  • Pacemakers (Implantable Pacemakers, External Pacemakers)
  • Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices))
  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart)
  • Other Products

By End-Use

  • Hospitals
  • Cardiac Clinics
  • Ambulatory Surgical Centers
  • Other End-Users

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Congestive Heart Failure Treatment Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Congestive Heart Failure Treatment Device market include Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Koninkilijke Philips N.V., Lepu Medical Technology Co. Ltd., LivaNova PLC, Medico S.P.A., Medtronic Plc, MicroPort Scientific Corporation, Oscor Inc., Schiller AG, Shree Pacetronix Ltd., St. Jude Medical Inc., Stryker Corporation, Terumo Corporation. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112115266

TABLE OF CONTENTS

1. PREFACE

  • 1.1. Report Description
    • 1.1.1 Objective
    • 1.1.2 Target Audience
    • 1.1.3 Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1 Market Research Process
    • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3. CONGESTIVE HEART FAILURE TREATMENT DEVICE - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Product
    • 3.7.2 Market Attractiveness Analysis By End-Use
    • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1 List of Raw Materials
    • 4.2.2 Raw Material Manufactures List
    • 4.2.3 Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1 Direct Marketing
    • 4.4.2 Indirect Marketing
    • 4.4.3 Marketing Channel Development Trend

5. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET ANALYSIS BY PRODUCT

  • 5.1. Overview By Product
  • 5.2. Historical and Forecast Data Analysis By Product
  • 5.3. Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD)) Historic and Forecast Sales By Regions
  • 5.4. External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator) Historic and Forecast Sales By Regions
  • 5.5. Pacemakers (Implantable Pacemakers, External Pacemakers) Historic and Forecast Sales By Regions
  • 5.6. Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices)) Historic and Forecast Sales By Regions
  • 5.7. Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart) Historic and Forecast Sales By Regions
  • 5.8. Other Products Historic and Forecast Sales By Regions

6. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET ANALYSIS BY END-USE

  • 6.1. Overview By End-Use
  • 6.2. Historical and Forecast Data Analysis By End-Use
  • 6.3. Hospitals Historic and Forecast Sales By Regions
  • 6.4. Cardiac Clinics Historic and Forecast Sales By Regions
  • 6.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
  • 6.6. Other End-Users Historic and Forecast Sales By Regions

7. GLOBAL CONGESTIVE HEART FAILURE TREATMENT DEVICE MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2 North America By Segment Sales Analysis
    • 7.3.3 North America By Country Sales Analysis
    • 7.3.4 United States Sales Analysis
    • 7.3.5 Canada Sales Analysis
    • 7.3.6 Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2 Europe By Segment Sales Analysis
    • 7.4.3 Europe By Country Sales Analysis
    • 7.4.4 United Kingdom Sales Analysis
    • 7.4.5 France Sales Analysis
    • 7.4.6 Germany Sales Analysis
    • 7.4.7 Italy Sales Analysis
    • 7.4.8 Russia Sales Analysis
    • 7.4.9 Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2 Asia Pacific By Segment Sales Analysis
    • 7.5.3 Asia Pacific By Country Sales Analysis
    • 7.5.4 China Sales Analysis
    • 7.5.5 India Sales Analysis
    • 7.5.6 Japan Sales Analysis
    • 7.5.7 South Korea Sales Analysis
    • 7.5.8 Australia Sales Analysis
    • 7.5.9 South East Asia Sales Analysis
    • 7.5.10 Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2 Latin America By Segment Sales Analysis
    • 7.6.3 Latin America By Country Sales Analysis
    • 7.6.4 Brazil Sales Analysis
    • 7.6.5 Argentina Sales Analysis
    • 7.6.6 Peru Sales Analysis
    • 7.6.7 Chile Sales Analysis
    • 7.6.8 Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2 Middle East & Africa By Segment Sales Analysis
    • 7.7.3 Middle East & Africa By Country Sales Analysis
    • 7.7.4 Saudi Arabia Sales Analysis
    • 7.7.5 UAE Sales Analysis
    • 7.7.6 Israel Sales Analysis
    • 7.7.7 South Africa Sales Analysis
    • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE CONGESTIVE HEART FAILURE TREATMENT DEVICE COMPANIES

  • 8.1. Congestive Heart Failure Treatment Device Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9. COMPANY PROFILES OF CONGESTIVE HEART FAILURE TREATMENT DEVICE INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. Abbott Laboratories
    • 9.3.1 Company Overview
    • 9.3.2 Company Revenue
    • 9.3.3 Products
    • 9.3.4 Recent Developments
  • 9.4. Biotronik SE & Co. KG
    • 9.4.1 Company Overview
    • 9.4.2 Company Revenue
    • 9.4.3 Products
    • 9.4.4 Recent Developments
  • 9.5. Boston Scientific Corporation
    • 9.5.1 Company Overview
    • 9.5.2 Company Revenue
    • 9.5.3 Products
    • 9.5.4 Recent Developments
  • 9.6. Koninkilijke Philips N.V.
    • 9.6.1 Company Overview
    • 9.6.2 Company Revenue
    • 9.6.3 Products
    • 9.6.4 Recent Developments
  • 9.7. Lepu Medical Technology Co. Ltd.
    • 9.7.1 Company Overview
    • 9.7.2 Company Revenue
    • 9.7.3 Products
    • 9.7.4 Recent Developments
  • 9.8. LivaNova PLC
    • 9.8.1 Company Overview
    • 9.8.2 Company Revenue
    • 9.8.3 Products
    • 9.8.4 Recent Developments
  • 9.9. Medico S.P.A.
    • 9.9.1 Company Overview
    • 9.9.2 Company Revenue
    • 9.9.3 Products
    • 9.9.4 Recent Developments
  • 9.10. Medtronic Plc
    • 9.10.1 Company Overview
    • 9.10.2 Company Revenue
    • 9.10.3 Products
    • 9.10.4 Recent Developments
  • 9.11. MicroPort Scientific Corporation
    • 9.11.1 Company Overview
    • 9.11.2 Company Revenue
    • 9.11.3 Products
    • 9.11.4 Recent Developments
  • 9.12. Oscor Inc.
    • 9.12.1 Company Overview
    • 9.12.2 Company Revenue
    • 9.12.3 Products
    • 9.12.4 Recent Developments
  • 9.13. Schiller AG
    • 9.13.1 Company Overview
    • 9.13.2 Company Revenue
    • 9.13.3 Products
    • 9.13.4 Recent Developments
  • 9.14. Shree Pacetronix Ltd.
    • 9.14.1 Company Overview
    • 9.14.2 Company Revenue
    • 9.14.3 Products
    • 9.14.4 Recent Developments
  • 9.15. St. Jude Medical Inc.
    • 9.15.1 Company Overview
    • 9.15.2 Company Revenue
    • 9.15.3 Products
    • 9.15.4 Recent Developments
  • 9.16. Stryker Corporation
    • 9.16.1 Company Overview
    • 9.16.2 Company Revenue
    • 9.16.3 Products
    • 9.16.4 Recent Developments
  • 9.17. Terumo Corporation
    • 9.17.1 Company Overview
    • 9.17.2 Company Revenue
    • 9.17.3 Products
    • 9.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

Product Code: VMR112115266

LIST OF TABLES

  • Market Snapshot
  • Drivers: Impact Analysis
  • Restraints: Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • Analysis By Product (USD MN)
  • Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD)) Market Sales By Geography (USD MN)
  • External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator) Market Sales By Geography (USD MN)
  • Pacemakers (Implantable Pacemakers, External Pacemakers) Market Sales By Geography (USD MN)
  • Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices)) Market Sales By Geography (USD MN)
  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart) Market Sales By Geography (USD MN)
  • Other Products Market Sales By Geography (USD MN)
  • Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Cardiac Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Other End-Users Market Sales By Geography (USD MN)
  • Global Congestive Heart Failure Treatment Device Market Sales By Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United States Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate By Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Congestive Heart Failure Treatment Device Report
  • Market Research Process
  • Market Research Methodology
  • Global Congestive Heart Failure Treatment Device Market Size, By Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis By Product
  • Market Attractiveness Analysis By End-Use
  • Market Attractiveness Analysis By Region
  • Value Chain Analysis
  • Global Market Analysis By Product (USD MN)
  • Defibrillators (Implantable cardioverter defibrillators (ICDs) (Transvenous ICD (Single-chamber ICDs Dual-chamber ICDs), Subcutaneous ICD)) Market Sales By Geography (USD MN)
  • External Cardioverter Defibrillator (Manual External Defibrillator, Automated External Defibrillator (Semi-Automated External Defibrillator, Fully Automated External Defibrillator), Wearable External Cardioverter Defibrillator) Market Sales By Geography (USD MN)
  • Pacemakers (Implantable Pacemakers, External Pacemakers) Market Sales By Geography (USD MN)
  • Cardiac Resynchronization Therapy Devices (Cardiac Resynchronization Therapy-Defibrillators (CRT-D) ( MRI Compatible CRT-D Devices, Conventional CRT-D Devices), Cardiac Resynchronization Therapy-Pacemakers (CRT-P) (MRI Compatible CRT-P Devices, Conventional CRT-P Devices)) Market Sales By Geography (USD MN)
  • Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVADs), Right Ventricular assist Devices (RVADs), Biventricular Assist Devices (BIVADs), Percutaneous Ventricular Assist Devices (PVADs), Total Artificial Heart) Market Sales By Geography (USD MN)
  • Other Products Market Sales By Geography (USD MN)
  • Global Market Analysis By End-Use (USD MN)
  • Hospitals Market Sales By Geography (USD MN)
  • Cardiac Clinics Market Sales By Geography (USD MN)
  • Ambulatory Surgical Centers Market Sales By Geography (USD MN)
  • Other End-Users Market Sales By Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!